Market Overview

Maxim Sees Major Upside In These Biotech Stocks

Maxim Sees Major Upside In These Biotech Stocks

In a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here's a rundown of what they had to say.

Athersys, Inc. (NASDAQ: ATHX)

Analysts believe that Athersys may have found a "sweet spot" for stroke treatment timing, as data from a phase II trial of MultiStem treatment one to two days after a stroke event is expected soon. Maxim has a Buy rating on Athersys and a $9.00 target for the stock.

Cytori Therapeutics Inc (NASDAQ: CYTX)

Cytori recently announced an emphasis on cost-cutting initiatives as it moves forward with its adipose-derives regenerative cell (ADRC) treatment trials. Analysts see big potential for the company in the scleroderma treatment space. Maxim has a Buy rating on Cytori and a $7.00 price target for the stock.

Ocata Therapeutics Inc (OTC: OCAT)

Analysts like the fundamental science and technology that Ocata brings to the table, but they are concerned about the near-term funding risk the company faces after it failed to close a $50 million funding raise in late 2014. Maxim has a Hold rating on Ocata.

OncoSec Medical Inc (OTC: ONCS)

Analysts like the results that OncoSec has seen so far in using up regulation of IL12 to drive cytotoxic T cells to attack tumors. Maxim has a Buy rating on OncoSec and a $3.00 target for the stock.

Tekmira Pharmaceuticals Corp (NASDAQ: TKMR)

Maxim believes that the company is undervalued following its merger with OnCor. Maxim's Buy rating and $27.00 price target for Tekmira is based on an average of sum-of-the-parts, free cash flow and discounted cash flow valuation models.

Latest Ratings for ATHX

Jun 2020B of A SecuritiesInitiates Coverage OnBuy
May 2020NeedhamMaintainsBuy
Aug 2019Dawson JamesInitiates Coverage OnBuy

View More Analyst Ratings for ATHX
View the Latest Analyst Ratings


Related Articles (ATHX)

View Comments and Join the Discussion!

Posted-In: MaximAnalyst Color Biotech Long Ideas Analyst Ratings Trading Ideas General Best of Benzinga

Latest Ratings

CAMTStifelInitiates Coverage On19.0
ELMDNorthland Capital MarketsInitiates Coverage On15.0
DKNGUBSInitiates Coverage On52.0
DIODTruist SecuritiesInitiates Coverage On84.0
TGTArgus ResearchUpgrades205.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at